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PURPOSE. To evaluate the outcomes of standard automated perimetry (SAP) in patients with
obstructive sleep apnea (OSA).
METHODS. Eighty OSA patients and 111 age-matched controls were consecutively and
prospectively enrolled. One eye per subject was randomly selected. All participants
underwent at least one reliable SAP (24-2 SITA Standard algorithm). The peripapillary retinal
nerve fiber layer thickness (RNFL) was measured with spectral-domain optical coherence
tomography (OCT). Patients with OSA were classified into three groups according to the
apnea/hypopnea index: mild, moderate, or severe OSA. Parameters of SAP and OCT were
compared between healthy controls and OSA patients. Correlation of apnea/hypopnea index
with OCT and SAP measurements were calculated.
RESULTS. Mean age, best-corrected visual acuity, and central corneal thickness were similar
between groups. Intraocular pressure, however, was lower in the OSA group. Mean deviation
of SAP was 0.23 6 0.8 dB in the control group and 1.74 6 2.8 dB in the OSA group (P <
0.001). Thickness of RNFL measured with OCT did not differ significantly between groups.
Patients with OSA showed reduced sensitivity at most points tested by white-on-white
perimetry compared with healthy individuals. The threshold values were more depressed in
the peripheral visual field. The apnea/hypopnea index was related to the SAP indices: Pearson
correlations were 0.432 with mean deviation, 0.467 with pattern standard deviation, and
0.416 with the visual field index (P < 0.001).
CONCLUSIONS. Patients with OSA exhibited reduced retinal sensitivity measured with SAP
compared with healthy controls.
Keywords: obstructive sleep apnea, visual field, optical coherence tomography, retinal nerve
fiber layer, optic disc
Obstructive sleep apnea (OSA) syndrome is a disordercharacterized by recurrent partial (hypopnea) or complete
(apnea) cessation of breathing during sleep. When the apnea/
hypopnea index (AHI) is at least five events per hour, OSA is
considered a clinical entity. Obstructive sleep apnea has a
reported prevalence of more than 20% in the general
population1,2 and is associated with cardiovascular, neurologic,
and endocrine disease.3–10 Sympathetic activation, oxidative
stress, and systemic inflammation are the main intermediary
mechanisms associated with sleep apnea and intermittent
hypoxia.11
Retinal ganglion cells provide a peripheral but accessible
window to central nervous system neurons that could be
subject to neuronal damage in association with OSA. Hypoxia
and oxidative stress are risk factors for neuronal death in retinal
diseases such as diabetic retinopathy and glaucoma.12,13 This
neuronal injury may result in thinning of the retinal nerve fiber
layer (RNFL) or reduced visual field (VF) sensitivity.
Noninvasive imaging technologies, such as spectral domain
optical coherence tomography (OCT), provide quantitative and
reproducible measurements for assessing RNFL thickness.
Numerous studies have confirmed the ability of OCT to detect
and monitor glaucoma,14–19 as well as to diagnose and follow-
up other disorders that affect the optic nerve head (ONH), such
as Parkinson disease, multiple sclerosis, and Alzheimer dis-
ease.20–25
The purpose of the present study was to compare the VF
and OCT parameters between healthy individuals and OSA
patients.
MATERIALS AND METHODS
The study design adhered to the tenets of the Declaration of
Helsinki and was approved by the Clinical Research Ethics
Committee of Aragon. Healthy eyes were recruited from the
hospital staff or relatives, and patients referred for refraction
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that underwent routine examination without abnormal ocular
findings, obesity, or history of symptoms related to OSA
(sleepiness, fatigue, snoring, adenoid facies, etc.). The group
with OSA was selected from among patients at the Respiratory
Unit of the Miguel Servet University Hospital in Zaragoza,
Spain. The group with OSA had no significant ophthalmic
disease and was not followed more frequently than the healthy
group. All individuals who met the inclusion criteria and
provided written informed consent were consecutively and
prospectively enrolled from January 2011 to December 2012.
All patients with OSA underwent an overnight sleep study
in the hospital for evaluation and diagnosis of OSA syndrome.
The diagnosis of OSA was based on a polysomnographic
evaluation comprising electroencephalography, electromyog-
raphy, electrocardiography, respiratory movements, and pulse
oximetry measurements. These tests were performed over a
minimum of 6 hours in the electrophysiology department of
our hospital. Dual respiratory inductance plethysmography
belt signals (thorax and abdomen) were used for scoring apnea
and hypopnea. Sleep and respiratory events in each patient
were recorded according to standard criteria.26 An apnea event
was defined as a decrease in the peak signal excursion ‡90%
for at least 10 seconds. A hypopnea event was defined as a
decrease in the peak signal excursion ‡ 30% (and <90%) from
the pre-event baseline for at least 10 seconds, and ‡3% oxygen
desaturation from the pre-event baseline, or an event
associated with arousal. Individuals with an AHI of at least
five events/h were considered to have OSA. Severity of OSA
was classified according to the AHI as follows: mild OSA when
the AHI was between 5 and 14 events/h, moderate OSA when
the AHI ranged from 15 to 19 events/h, and severe OSA when
the AHI was higher than 19 events/h.
Inclusion criteria were best-corrected visual acuity of 20/40
or better, refractive error within6 5.00 diopters (D) equivalent
sphere, and 62 D astigmatism; transparent ocular media
(nuclear color and opalescence, cortical or posterior subcap-
sular lens opacity < 1) according to the Lens Opacities
Classification System III system27; and open anterior chamber
angle. Exclusion criteria were previous intraocular surgery,
diabetes, history of any ocular or neurologic disease, and any
treatment with oxygen therapy or noninvasive mechanical
ventilation. Patients with glaucomatous standard automated
perimetry (SAP) defects, glaucomatous optic disc morphology,
or intraocular pressure (IOP) > 20 mm Hg were also excluded
from the study. A total of 80 patients with OSA and 111 healthy
subjects were included in the statistical analysis.
Study Protocol
All examinations were performed within 6 weeks of the
subject’s date of enrollment into the study. Participants
underwent a comprehensive ophthalmologic examination:
clinical history, best corrected visual acuity (BCVA), slit-lamp
biomicroscopy of the anterior segment, gonioscopy, Goldmann
applanation tonometry, central corneal ultrasonic pachymetry
(OcuScan RxP; Alcon Laboratories, Inc., Irvine, CA, USA), and
ophthalmoscopy of the posterior segment.
Two SAPs were performed using a Humphrey field analyzer
(model 750i; Zeiss Humphrey Systems, Dublin, CA, USA), with
the 24-2 SITA Standard strategy. Subjects completed the
perimetry tests before undergoing any clinical examination or
structural test, and each test was performed at least 3 days
apart to avoid a fatigue effect. All participants had a reliable
SAP (false positives and negatives < 15%, fixation losses <
20%) in the second attempt. The data from the last perimetry
test were used for the statistical analysis to minimize the
learning effect.
Peripapillary RNFL thickness was measured using the Optic
Disc Cube 200 3 200 acquisition protocol of the OCT device
(Cirrus HD, software version 6.2; Carl Zeiss Meditec, Dublin,
CA, USA). This protocol scanned a 63 6 mm2 area centered on
the optic disc. A 3.46-mm diameter circular scan, containing
256 A-scans, was automatically targeted around the optic disc
to provide the RNFL thicknesses of the four quadrants and at
each of the 12 clock-hour positions. Left eyes were converted
to a right eye format. All images were obtained by the same
experienced technician with a signal/strength ratio greater
than 6/10.
Statistical Analysis
Statistical analyses were performed using statistical software
(IBM SPSS, version 21.0; IBM Corporation, Somers, NY, USA).
When both eyes fulfilled the inclusion criteria, only one eye
per subject was randomly selected for the study. All study
variables had a normal distribution as verified with the
Kolmogorov-Smirnov test (K-S of 1 sample). Demographics,
SAP, and OCT parameters were compared between groups
with Student’s t-tests. The Bonferroni correction for multiple
comparisons was applied, resulting in a significance level of P
< 0.002. Pearson correlations were calculated between the
AHI and VF indices.
RESULTS
The clinical characteristics of the study sample are detailed in
Table 1. A total of 111 healthy controls and 80 OSA patients
were included in the statistical analysis. Mean age was 50.78 6
9.4 years in the control group and 48.8 6 11.5 years in the
OSA group (P¼ 0.19). Central corneal thickness was similar in
both groups (551.66 6 35.6 lm in healthy subjects and 560.01
6 30.1 lm in OSA patients; P¼ 0.09), but intraocular pressure
was significantly lower in the OSA group (17.09 6 2.5 mm Hg
in healthy subjects and 13.99 6 2.6 mm Hg in OSA patients; P
< 0.001).
Main SAP indices differed significantly between the groups.
Mean deviation (MD) was lower in the OSA group (0.236 0.8
dB vs.1.74 6 2.8 dB; P < 0.001), pattern standard deviation
(PSD) was higher in the OSA group (1.42 6 0.2 vs. 1.98 6 1.1;
P < 0.001), and the visual field index (VFI) was lower in the
TABLE 1. Clinical Characteristics of the Study Population
Control OSA
P*Mean SD Mean SD
Age, y 50.78 9.46 48.83 11.52 0.20
BCVA, logMAR 0.04 0.05 0.02 0.05 0.02
Pachymetry, lm 551.66 35.60 560.01 30.12 0.10
IOP, mm Hg 17.09 2.46 13.99 2.60 <0.001
MD SAP, dB 0.23 0.82 1.74 2.77 <0.001
PSD SAP 1.42 0.23 1.98 1.05 <0.001
VFI SAP 99.52 0.70 97.51 4.83 <0.001
SAP test duration, s 319.90 39.31 331.40 45.52 0.06
Fixation losses SAP, % 3.79 3.38 4.23 4.17 0.42
False positive rate SAP, % 1.07 1.25 1.05 0.98 0.90
False negative rate SAP, % 0.61 0.98 0.72 0.95 0.44
Systolic pressure, mm Hg 118.98 12.32 124.11 14.76 0.01
Diastolic pressure, mm Hg 75.83 8.82 78.74 9.78 0.03
BMI, kg/m2 24.25 4.78 27.82 7.21 <0.001
n 111 80
* Student’s t-test. Significant differences (P  0.001) are highlighted
in bold font.
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OSA patients (99.52 6 0.7 vs. 97.51 6 1.1; P < 0.001).
Reliability indices of SAP and test time were similar between
groups. Systolic and diastolic blood pressure did not differ
between groups, but body mass index (BMI) was higher in the
OSA group.
Table 2 shows the VF threshold values at each of the 52 VF
points tested by the grid of the 24-2 SITA Standard strategy (Fig.
1). Most of these points were depressed in OSA patients
compared with healthy controls (Figs. 2, 3). The measurements
of OCT revealed that the two groups were not different in
peripapillary RNFL thickness at each of the 12 clock-hour
positions, in the four quadrants, or in the average thickness
(Table 3). Moreover, OSA patients grade 2 (moderate) and
grade 3 (severe) combined or grade 3 alone had RNFL
thicknesses similar to those in the control group (Table 4).
The VF indices of the SAP correlated moderately with the
AHI: the Pearson correlation coefficients between AHI and MD,
PSD, and VFI were0.432, 0.467, and 0.416, respectively (P
< 0.001).
DISCUSSION
The pathogenesis of neurodegeneration in OSA syndrome is
unclear. Intermittent upper airway obstruction in OSA patients
during sleep can increase carbon dioxide levels while
decreasing oxygen levels, thereby reducing the oxygen
saturation during a variable period of sleep. These alterations
induce oxidative stress, and lead to increased vascular
resistance and endothelial dysfunction. Hypoxia and hyper-
capnia episodes cause autonomic, hemodynamic, and neuro-
rendocrine changes.28,29 Obstructive sleep apnea syndrome is
associated with neurovascular disease, cardiovascular disease,
arterial hypertension, pulmonary hypertension, arrhythmia,
and other systemic disorders.30
The oxygenation-reoxygenation process in OSA syndrome
can compromise normal vascularization and perfusion of the
ONH similar to glaucoma, based on the vascular theory
proposed by Anderson.31 This theory suggests that the damage
to the ONH in glaucoma is caused, at least in part, by persistent
or temporary ischemia. Failure of the blood supply from the
posterior ciliary arteries to the short posterior ciliary arteries
could lead to nonperfusion of the anterior part of the ONH and
neuronal ischemia. The affected ONH microcirculation would
interfere with axonal nutrition and axoplasmic flow. Calvo et
al.32 reported that abnormal retrobulbar blood flow velocities
measured by color Doppler ultrasound may be a risk factor for
conversion to glaucoma. On the other hand, Lin et al.33
recently suggested that OSA is associated with an increased
risk of a subsequent diagnosis of open-angle glaucoma during a
5-year follow-up period after the diagnosis of OSA.
We hypothesized that these vascular phenomena could
affect VF and ONH morphology in OSA patients and that such
changes could be measured by SAP and OCT, respectively.
Retinal sensitivity was reduced in OSA patients compared with
the control group, although we detected no significant
differences in the RNFL thickness measurements. The topo-
graphic correspondence between VF regions and RNFL
thickness in humans is moderate in glaucoma patients due to
the high variability of normal human ONH morphology and the
intertest variability of SAP.34–36 The agreement between the
SAP and OCT results in OSA patients is expected to be similar
to that in healthy individuals.34–38
Previous studies using different imaging techniques to
measure RNFL thickness in OSA patients described contradic-
tory results.39–44 Some studies reported decreased RNFL
thickness in OSA patients, in contrast to the present
results,39,40,42 whereas others found no correlation between
RNFL thickness and AHI.42 Still others observed a significant
decrease in the RNFL thickness in patients with severe OSA.44
All of these findings, however, were based on different imaging
technologies than used in the present study. We measured the
RNFL thickness with a spectral-domain OCT (Cirrus), whereas
TABLE 2. Differences in Sensitivity Threshold Values (dB) of Tested VF
Points in SAP Between Control and OSA Groups
Control Group OSA Group
P*Mean SD Mean SD
SAP 1 27.24 2.22 25.59 3.79 <0.001
SAP 2 28.06 2.16 26.04 4.48 <0.001
SAP 3 27.33 1.98 25.11 4.83 <0.001
SAP 4 27.18 2.63 24.78 5.34 <0.001
SAP 5 28.62 2.24 27.04 3.40 <0.001
SAP 6 29.70 1.59 28.26 2.76 <0.001
SAP 7 29.71 1.44 28.16 3.09 <0.001
SAP 8 29.27 1.61 26.99 4.72 <0.001
SAP 9 29.39 2.01 28.08 3.17 0.001
SAP 10 29.13 2.27 26.75 5.33 <0.001
SAP 11 28.46 2.26 26.41 4.40 <0.001
SAP 12 30.43 1.42 29.18 2.60 <0.001
SAP 13 31.61 1.27 29.93 4.54 <0.001
SAP 14 31.51 1.40 30.51 2.89 0.002
SAP 15 31.05 1.37 29.60 3.06 <0.001
SAP 16 30.32 1.65 28.85 3.31 <0.001
SAP 17 30.20 1.92 28.68 3.81 <0.001
SAP 18 28.68 2.22 26.69 4.93 <0.001
SAP 19 26.86 2.61 25.06 5.16 0.002
SAP 20 29.00 1.68 27.53 3.73 <0.001
SAP 21 31.30 1.35 29.90 3.15 <0.001
SAP 22 32.38 1.14 30.74 4.00 <0.001
SAP 23 32.68 1.24 31.38 3.34 <0.001
SAP 24 32.42 1.35 30.90 3.43 <0.001
SAP 25 31.41 1.52 30.09 3.44 <0.001
SAP 26 29.84 2.03 27.64 4.72 <0.001
SAP 27 26.89 2.66 24.81 5.71 0.001
SAP 28 29.38 1.68 27.61 4.04 <0.001
SAP 29 31.60 1.47 30.36 2.84 <0.001
SAP 30 32.50 1.15 31.23 3.05 0.001
SAP 31 32.66 1.27 31.87 2.39 0.004
SAP 32 32.66 1.39 31.66 2.66 0.001
SAP 33 31.76 1.49 30.41 2.76 <0.001
SAP 34 30.25 2.04 28.64 3.77 <0.001
SAP 35 28.82 1.96 27.33 3.65 <0.001
SAP 36 30.75 1.44 29.70 3.23 0.003
SAP 37 32.22 1.34 31.26 2.87 0.002
SAP 38 31.91 1.33 30.91 2.52 <0.001
SAP 39 32.07 1.20 31.00 2.77 <0.001
SAP 40 31.61 1.79 30.68 3.06 0.009
SAP 41 30.68 1.72 29.83 3.33 0.02
SAP 42 29.68 2.09 28.13 4.12 0.001
SAP 43 30.05 1.97 28.49 3.80 <0.001
SAP 44 30.62 1.43 29.68 2.84 0.003
SAP 45 30.95 1.57 29.54 3.37 <0.001
SAP 46 30.77 1.61 29.53 3.15 <0.001
SAP 47 30.93 1.49 29.85 3.45 0.004
SAP 48 30.92 1.69 28.85 4.39 <0.001
SAP 49 28.92 2.20 27.16 4.25 <0.001
SAP 50 29.16 1.95 27.31 5.16 0.001
SAP 51 29.93 1.88 28.14 4.20 <0.001
SAP 52 30.00 2.05 28.10 4.90 <0.001
* Student’s t-test. Significant differences (P  0.001) are highlighted
in bold font.
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time-domain OCT40,41,43 or scanning laser polarimetry39,42
were used in the previous studies.
If outcomes of VF or OCT differed between groups, these
parameters could potentially be used as biomarkers for
neuronal damage in OSA patients. Although we detected no
changes in the peripapillary RNFL thickness measured by OCT,
there were differences in the retinal sensitivity and VF indices.
Patients with OSA exhibited diffuse decreased retinal sensitiv-
ity without localized VF defects typical of other pathologies
such as glaucoma. This generalized reduction of the threshold
values, particularly in the peripheral VF, could be explained by
diffuse vascular damage to the retinal ganglion cells, causing
axonal loss and VF depression. This injury to the retinal
ganglion cells may lead to dysfunction of the visual pathway
that could be identified by a functional test, such as SAP, while
the anatomy is relatively unaffected and therefore undetected
by a structural test, such as OCT. Moreover, OSA patients
(especially those with more advanced disease) may have
experienced at least one apnea/hypopnea event during the VF
examination, which could decrease attention and impair
testing ability, resulting in reduced retinal sensitivity, even
when the SAP reliability criteria were maintained within
normal limits.
Quantitative variables MD, PSD, and VFI could be used to
monitor the progression of the disease, treatment with oxygen
therapy, or noninvasive mechanical ventilation.45 The main
criterion to begin treatment with continuous positive airway
pressure (CPAP) is a graduated severity of OSA syndrome
(moderate and severe). Thus, any changes detected in the VF
could help to support the decision to begin CPAP in OSA
patients.
Huseyinoglu et al.44 also reported worse MD and PSD
(Octopus perimetry) in OSA subgroups compared to a control
group. Lin et al.,40 however, found no differences in the MD of
SAP (30-2 strategy) between OSA patients and healthy controls.
Different study designs and populations, inclusion and
exclusion criteria, tests performed, and the level of OSA
damage make it difficult to compare the results among several
studies.
A limitation of the present study was that the control group
did not undergo an overnight sleep study and we assumed that
they had no apnea/hypopnea events per hour. Ideally, they
FIGURE 1. Grid of visual field points tested by the 24-2 SITA Standard algorithm of SAP. These locations were numbered as shown based on the side
of the eye.
FIGURE 2. Mean SAP sensitivity threshold values (dB) in the control group (left graph) and the OSA group (right graph) for a right eye. The group
with OSA had reduced sensitivity at most points tested by white-on-white perimetry compared with the control group, mainly in the peripheral
visual field.
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should have also undergone a polysomnographic evaluation for
one night, but this evaluation is costly and we could not justify
its inclusion in the study protocol because the criteria used to
select the control group minimized the possibility of including
an OSA patient by chance (exclusion criteria for the control
group: obesity and symptoms related to OSA). Nevertheless, if
all controls were chosen according to a strictly normal sleep
study, we would have selected a ‘‘super-healthy’’ control
group. In addition to the effect size (difference between
groups), these factors would probably lead to a larger retinal
sensitivity reduction than the one observed.
In the present study, OCT did not demonstrate neurode-
generative changes in OSA patients, but retinal sensitivity was
significantly reduced in OSA patients compared with healthy
subjects. Given the issues related with subjective perimetry,
studies employing objective functional testing (e.g., electro-
physiology test) are warranted, as well as further prospective
longitudinal studies to clarify the role of VF and OCT as a
neurodegenerative marker in OSA syndrome.
Clinicians should be aware that OSA patients may have
nonglaucomatous VF defects, which should be differentiated
from true glaucomatous optic neuropathy.
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